MAPS in the Media

FDA authorizes clinical trials to study cannabis use for veterans with PTSD | Stars and Stripes

FDA gives green light to PTSD marijuana study in veterans | The Hill

FDA Approves Long-Awaited Clinical Trial Of Smoked Marijuana To Treat PTSD In Veterans | Marijuana Moment

Weed for PTSD? Eager for Better Cannabis Science, F.D.A. Clears Study. | The New York Times

Setback Or Opportunity? FDA Rejects MDMA For PTSD | Forbes

Despite FDA setback, psychedelic pioneer Rick Doblin is unfazed about MDMA’s prospects – The Washington Post

Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy | STAT News

Opinion: FDA ruling on ecstasy for PTSD is a bad trip for suffering patients | Washington Post

Bennet, Tillis, Sinema, Paul, 15 Colleagues Call on FDA to Rely on Scientific Evidence for MDMA-Assisted Therapy to Treat Post-Traumatic Stress Disorder

Bergman Leads 60 Members in Letter to Highlight New Groundbreaking Therapy, Stop Veteran Suicide

Making Sense with Sam Harris: The Future of Psychedelic Medicine 2

The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy | Chacruna